Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$73,130,792
-$22,278,361 QoQ
Shares Held
1,524,511
-38.3% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. RPRX ranks #4 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,130,792 | 1,524,511 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $95,409,153 | 2,469,181 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $87,556,880 | 2,481,771 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,679,472 | 296,405 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,037,151 | 1,960,718 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,548,068 | 1,589,497 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,740,386 | 1,934,973 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,278,789 | 1,679,135 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $23,405,551 | 770,680 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $58,020,653 | 2,065,527 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $46,433,066 | 1,710,872 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $36,253,003 | 1,179,343 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,448,114 | 428,757 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,301,618 | 792,045 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,989,510 | 323,283 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,368,113 | 56,330 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,513,472 | 269,853 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,333,934 | 58,568 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,006,992 | 83,204 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,563,916 | 86,946 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $3,017,596 | 71,728 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||